CWBR vs. NOVN, ABVC, VAXX, OGEN, CMMB, ATHE, NCNA, KTRA, CANF, and UPC
Should you be buying CohBar stock or one of its competitors? The main competitors of CohBar include Novan (NOVN), ABVC BioPharma (ABVC), Vaxxinity (VAXX), Oragenics (OGEN), Chemomab Therapeutics (CMMB), Alterity Therapeutics (ATHE), NuCana (NCNA), Kintara Therapeutics (KTRA), Can-Fite BioPharma (CANF), and Universe Pharmaceuticals (UPC). These companies are all part of the "pharmaceutical preparations" industry.
CohBar (NASDAQ:CWBR) and Novan (NASDAQ:NOVN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, community ranking, dividends, earnings, analyst recommendations, valuation and risk.
In the previous week, CohBar's average media sentiment score of 0.00 equaled Novan'saverage media sentiment score.
CohBar has a net margin of 0.00% compared to Novan's net margin of -128.61%. CohBar's return on equity of 0.00% beat Novan's return on equity.
Novan received 221 more outperform votes than CohBar when rated by MarketBeat users. However, 72.00% of users gave CohBar an outperform vote while only 55.71% of users gave Novan an outperform vote.
CohBar has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, Novan has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500.
2.5% of CohBar shares are held by institutional investors. Comparatively, 14.5% of Novan shares are held by institutional investors. 6.5% of CohBar shares are held by company insiders. Comparatively, 1.3% of Novan shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
CohBar has higher earnings, but lower revenue than Novan. CohBar is trading at a lower price-to-earnings ratio than Novan, indicating that it is currently the more affordable of the two stocks.
Summary
CohBar beats Novan on 7 of the 12 factors compared between the two stocks.
Get CohBar News Delivered to You Automatically
Sign up to receive the latest news and ratings for CWBR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CWBR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
